Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus. [electronic resource]
Producer: 20190128Description: 602-604 p. digitalISSN:- 1524-4539
- Administration, Oral
- Blood Platelets -- drug effects
- Diabetes Mellitus -- blood
- Drug Resistance
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin -- administration & dosage
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Function Tests
- Prasugrel Hydrochloride -- administration & dosage
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Receptors, Purinergic P2Y12 -- blood
- Risk Factors
- ST Elevation Myocardial Infarction -- blood
- Ticagrelor -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Letter; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.